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Edited by Sandro SonninoAbstract There are three known splice variants of Type Ic
phosphatidylinositol 4-phosphate 5-kinase (PIPkin Ic): PIPkins
Ic87, Ic90, and the most recently cloned (Giudici, M.L., Emson,
P.C. and Irvine, R.F. (2004) A novel neuronal-speciﬁc splice var-
iant of Type I phosphatidylinositol 4-phosphate 5-kinase isoform
gamma. Biochem. J. 379, 489–496) PIPkin IcC (here called
PIPkin Ic93). Here, we have explored the subcellular localisa-
tion and mobility of Type I PIPkins in transfected cells by con-
focal microscopy and ﬂourescence recovery after photobleaching.
The unique behaviour shown by PIPkin Ic93 is consistent with its
suggested distinct function. Moreover, the markedly diﬀerent
localisation and mobility of active versus inactive PIPkin Ic93
provide insights into the factors that dictate cellular targeting
of Type Ic PIPkins.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V.
Keywords: Phosphatidylinositol 4-phosphate;
Phosphatidylinositol 4-phosphate 5-kinase; Fluorescence
recovery after photobleaching
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PtdIns(4,5)P2 is now known to fulﬁl many intracellular func-
tions (see [1,2] for reviews), and this is reﬂected in part by the
diversity of the family of enzymes principally responsible for
PtdIns(4,5)P2 synthesis [3], the Type I PtdIns4P 5-kinases
(Type I PIPkins). The three known mammalian isoforms can
exhibit distinct functions (e.g. [4,5] and see [6] for review),
and moreover, PIPkin Ic widens this potential repertoire by
existing as three splice variants. Diﬀerential splicing of genes
is a general way that evolution uses to enhance or modify gene
diversity [7], and so studying the diﬀerence between the splice
variants of PIPkin Ic can not only provide a way of exploring
the diversity of inositide signalling, but can also serve as a spe-
ciﬁc exemplar to illustrate the physiological function of splice
variation.
For example, the two PIPkin Ic spliceoforms ﬁrst cloned [8],
PIPkin Ic90 and Ic87, have distinct functions. Two groups
have shown how both PIPkin Ic90 and Ic87 are localised pri-
marily to the plasma membrane, but only PIPkin Ic90 is tar-Abbreviations: Type I PIPkin, phosphatidylinositol 4-phosphate 5-ki-
nase; FRAP, ﬂuorescence recovery after photobleaching
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talin [9,10]. This interaction is regulated in a complex manner
by phosphorylation [11,12], and may play an important role in
presynaptic vesicle recycling [13,14]. Moreover, a further func-
tional separation of these two splice variants is revealed by the
demonstration [15] that PLD2 speciﬁcally stimulates integrin-
mediated adhesion by a process involving PIPkin Ic87, but
not PIPkinIc90.
Recently, we extended the known splice variants of PIPkin
Ic by discovering a third spliceoform, which is similar to PIP-
kin Ic90, but with an extra 26 amino acids inserted 26 residues
from the C-terminus [16]. We originally called this variant PIP-
kin IcC, but here, to introduce consistency in nomenclature
with more extensive recent work on PIPkin Ics (see above),
we refer to PIPkin IcC as Ic93. PIPkin Ic93 is apparently re-
stricted in its expression to deﬁned neurons in the brain, and
we have suggested that it has a unique function in that synthe-
sis a pool of PtdIns(4,5)P2 which plays a role in the mainte-
nance of neuronal processes [16].
Here, we document a comparative study on the subcellular
localisation of all three PIPkin Ic splice variants. We ﬁnd that
PIPkin Ic93 has a localisation and mobility entirely diﬀerent
from the other Type I PIPkins, and that its enzymic activity al-
ters its properties.2. Materials and methods
2.1. Materials
FLAG-constructs were obtained as previously described [16]. GFP-
labelled PIPKin Ia was a gift from K.A. Hinchliﬀe, (Department of
Physiology & Pharmacology, University of Manchester, UK).2.2. Cell culture
COS-7 cells and HEK-293 cells were maintained in Dulbecco’s Mod-
iﬁed Eagles Medium (DMEM) (Invitrogen, UK) containing 10% foetal
bovine serum (FBS) (Invitrogen), 50 U/ml penicillin and 50 U/ml
streptomycin at 37 C, 5% CO2. Cells were seeded onto glass coverslips
(Menzel-Glaser-Germany) pre-coated with poly-D-lysine (Sigma, UK)
in case of HEK-293 cells.2.3. Transfection
Transfection of COS-7 cells was done by the calcium-phosphate
technique. Cells were incubated overnight with calcium-phosphate/
DNA precipitate in DMEM 10%FBS followed by glycerol-shock
and then kept in the growth medium.
HEK-293 cells were transfected using FuGene6 Transfection reagent
(Roche Molecular Biochemicals, USA).2.4. Photobleaching
This exactly followed the protocol in Ref. [17].by Elsevier B.V. Open access under CC BY-NC-ND license.
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The mobile fraction (Mf) of a protein is the amount of protein that is
free to move within the ROI. In ﬂuorescence recovery after photoble-
aching (FRAP) experiments,Mf is estimated by the amount of ﬂuores-
cence recovery in the ROI due to the diﬀusion of the mobile ﬂuorescent
protein from outside the ROI.
The computation of mobile fractions was performed exactly as in
Brough et al. [17].2.6. Diﬀusion constant
The diﬀusion constant (D, lm2/s) measures the Brownian movement
of a ﬂuorescent protein in the ROI over time and was calculated using
the Siggia simulation model [18] with software that was a gift from E.
Snapp and J. Lippencott-Schwartz see also [17]. D is obtained after
comparing experimental and simulated recovery plots. Only experi-
ments with a good ﬁt of experimental and simulated data were ac-
cepted to generate the D value.2.7. Immunoﬂuorescence
This was performed exactly as in Giudici et al. [16].Fig. 1. Localisation of Type I PIPkins in COS-7 cells. Confocal
images of COS cells transfected with Type Ic PIPkin constructs are
shown as follows: (A) GFP-PIPkin I a; (B) FLAG-PIPkin Ib; (C)
FLAG-PIPkin Ic90; (D) FLAG-PIPkin Ic87; (E) FLAG-PIPkin Ic93;
(F) FLAG-PIPkin Ic93 kinase-dead (D316K). Cells were cultured for3. Results and discussion
3.1. Cell transfection
Our initial description of PIPkin Ic93 [16] led us to the con-
clusion that it is expressed only in the brain, and in only some
speciﬁc neurons, so for an initial exploration of its localisation
we used transfection of cerebellar granule neurons with PIPkin
Ic93 constructs. However, we have found these cells unsuitable
for exploration of the subcellular localisation of PIPkin Ics be-
cause of their small size and thin processses. So we turned to
COS and HEK-293 cells, which, although subject to the caveat
that they do not, as far as we know, normally express PIPkin
Ic93, are very much more amenable for investigating subcellu-
lar localisation of proteins by confocal microscopy and FRAP.
By directly comparing diﬀerent isoforms and splice variants we
can shed indirect but informative light on the properties of
Type I PIPkins.2–4 h after transfection, then ﬁxed and stained as described under
Section 2.3.2. Localisation of type I PIPkin isoforms in COS cells
In all our experiments described here, we used a short trans-
fection of the cells (4 h maximum), because longer trans-
fections (e.g. 24 h) caused obvious changes in cellular
morphology. We believe that by keeping the expression levels
to the minimum consistent with detection, we minimise any
potential artefacts due to over-expression. When we then
transfected GFP- or FLAG-tagged PIPkins Ia, Ib, Ic90 and
Ic87 into COS cells, all four of them showed a predominantly
plasma membrane localisation (Fig. 1).
We should note that there is some controversy as to the
accuracy with which acute transfection of Type I PIPkins re-
ﬂects their true endogenous distribution. Thus, for example,
human PIPkin Ib (the ortholog of mouse PIPkin Ia) has been
assigned a speciﬁc endogenous perinuclear location [4], yet it
shows a plasma membrane localisation on transfection
([19,20] and Fig. 1A). A possible explanation is that once the
endogenous binding sites for PIPkin Ib have been saturated,
the excess goes by default to the plasma membrane, where
its PtdIns4P substrate is located. Indeed, such a plasma mem-
brane localisation caused by substrate binding has been sug-
gested by the work of Kunz et al. [19,20], who, by changing
the speciﬁcity of a Type I PIPkin (which uses PtdIns4P as a
substrate) to that of Type II PIPkin (which uses PtdIns5P),and vice versa, showed that changing substrate speciﬁcity of
PIPkins can alter their localisation. Their data suggested that
it is primarily binding to PtdIns4P in the plasma membrane
which dictates the localisations shown in Fig. 1. However, it
is important to note that Kunz et al. [20] also showed that this
is not the whole story, and some form of protein–protein inter-
action may also be involved in the plasma membrane localisa-
tion of Type I PIPkins.
Whatever the true physiological localisation of these Type I
PIPkins, what the data in Fig. 1 show is that in these experi-
ments PIPkin Ic93 (Fig. 1E) is strikingly diﬀerent from all
the four other isoforms or splice variants. It displays a pre-
dominantly intracellular localisation, being apparently associ-
ated with some kind of structures that are partly vesicular or
punctate. We explored its possible co-localisation with cell
markers for Golgi, e.r. and mitochondria, and found no con-
vincing co-localisation (not shown). Moreover, although we
were able to see some occasional and partial co-localisation
with some MVB markers such as EEA-1, a marker of early
endosomes, it was not always evident, and certainly did not
co-localise with most of the PIPkin Ic93.
Fig. 2. FRAP of Type Ic PIPkins in HEK-293 cells. Representative
FRAP data from HEK-293 cells are shown – quantitative analysis of
many cells is given in Table 1. Cells were transfected with the GFP-
constructs designated below, and confocal images of representative
cells for each are shown in A, B, C and D. For each of these cells, on
the right (E, F, G and H, respectively) is shown a typical bleach
followed by recovery (see Section 2 for details). Fluorescence values
indicated correspond to pre-bleaching (i), immediately after bleaching
(ii), and recovery (iii). Constructs are: A/E, GFP- PIPkin Ic90; B/F,
GFP- PIPkin Ic87; C/G, GFP-PIPkin Ic93; D/H, GFP-PIPkin Ic93
kinase-dead.
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In parallel experiments in HEK-293 cells, we noted that the
diﬀerence between the localisation of PIPkins Ic90, Ic87 and
Ic93 was much less obvious (Fig. 2), and in many cells (see
Fig. 2C for example) PIPkin Ic93 appeared similar to Ic87
and Ic90 in being mostly close to the plasma membrane. How-
ever, more detailed analysis by FRAP revealed that this simi-
larity was largely superﬁcial.
For PIPkins Ic9 and Ic87, the majority of protein was mo-
bile, with mobile fractions (Mfs) of 85% and 92%, respectively
(Fig. 2A, E and B, F and Table 1). Analysis of the data by mea-
surement of the t1/2 by non-linear regression followed by gener-
ation of diﬀusion coeﬃcients (D) by the Siggia et al. simulation
([18] and see Section 2), yielded D values of 0.41 lm2 s1 and
0.42 lm2 s1 for PIPkin Ic90 and PIPkin Ic87, respectively (Ta-
ble 1). These diﬀusion coeﬃcients are comparable with the va-
lue of D = 0.71 lm2 s1 which we obtained in an identical
experimental protocol for GFP-GAP1IP4BP [17], a protein that
is probably attached to the plasma membrane by its interaction
with PtdIns(4,5)P2 [21]. However, in discussing those experi-
ments [17] we also raised the possibility that additional interac-
tions with plasma-membrane proteins might account for the
lower mobility of GAP1IP4BP compared with, for example,
GAP1m (D = 3.83 lm2 s1), when it is transiently attached to
the plasma membrane by its interaction with receptor-gener-
ated PtdIns(3,4,5) P3. Indeed, it is interesting that the diﬀusion
coeﬃcents of PIPkins Ic90 and Ic87 here are actually closer to
the value we obtained (0.38 lm2 s1) for GFP-ICAM, a trans-
plasma membrane protein [17].
We should add that in some earlier experiments we also mea-
sured the mobility of GFP-tagged murine PIPkin Ia, and not
surprisingly it showed parameters very similar to PIPkins
Ic90 and Ic87 (D. Brough, M-L.G. and R.F.I., unpublished).
Overall, our ﬁnding that the mobility of plasma membrane-
associated Type I PIPkins is so slow supports the suggestion
of Kunz et al. [19,20] that interactions with other membrane
proteins also play a role in localising Type I PIPkins to the
plasma membrane.
3.4. FRAP of PIPkin Ic93
The mobility of PIPkin Ic93 was markedly diﬀerent from the
Ic90 and Ic87 splice variants. Most of the enzyme was immo-
bile, the mobile fraction being only 36% (Fig. 2C, G and Table
1). This is consistent with PIPkin Ic93 being conﬁned to vesic-
ular/tubular structures (Fig. 1), such that, although it may dif-
fuse within the vesicle/tubule structure, its recovery within the
ROI is governed by the diﬀusion of the structures themselves
through the cytoplasm, which is too slow to be measured over
the time course of these experiments. If this is a correct inter-
pretation, then we suggest that these structures are close to the
plasma membrane in HEK-293 cells. Whatever the explana-
tion, the diﬀerence between PIPkin Ic93 and the other two
splice variants (which are essentially fully mobile) is striking.
We cannot compute a diﬀusion coeﬃcient for PIPkin Ic93 in
the presence of so much immobile fraction using the Siggia
et al. simulation [18], but we were able to gauge an approxi-
mate t1/2 for the mobile fraction of PIPkin Ic93 as about
16 s, similar to that of the almost fully mobile PIPkins Ic90
and Ic87, above (Table 1). We assume that this may be a small
proportion of PIPkin Ic93 which is attached to the plasma
membrane in a way similar to the other isoforms, but we can-
not take this observation further in this context.3.5. Kinase-dead PIPkin Ic90
We previously employed two kinase-dead constructs of PIP-
kin Ic90 as controls (for the eﬀects of kinase-dead PIPkin Ic93)
Table 1
Mobility of Type I PIPkins by FRAP
Protein Mf (%) t1/2 ± S.E.M. (s) D ± S.E.M. (lm
2/s)
PIPkin Ic87 92.16 ± 3.38 (n = 7) 16.25 ± 2.45 (n = 7) 0.42 ± 0.13 (n = 10)
PIPkin Ic90 84.65 ± 3.94 (n = 8) 16.03 ± 1.03 (n = 8) 0.41 ± 0.09 (n = 9)
PIPkin Ic93 35.63 ± 3.22 (n = 14) 15.92 ± 2.89 (n = 14) –
PIPkin Ic90 kinase-dead 77.90 ± 4.50 (n = 10) 32.74 ± 3.37 (n = 10) 0.29 ± 0.05 (n = 11)
PIPkin Ic93 kinase-dead 92.16 ± 1.06 (n = 6) 4.25 ± 1.42 (n = 6) 3.54 ± 0.67 (n = 7)
The table shows the data derived from FRAP experiments on HEK-293 cells transfected with the GFP-tagged constructs shown in the left-hand
column. For details see text and Section 2, and for examples of typical cells see Fig. 2.
Fig. 3. Co-expression of kinase-dead PIPkin Ic93 with active PIPkin
Ic93 or Ic90. HEK-293 cells were co-transfected with GFP-tagged
kinase dead PIPkin Ic93, and FLAG-tagged constructs of either active
PIPkin Ic93 (A,C) or Ic90 (B,D). They were imaged under confocal
microscopy, and representative images are shown. Fig. 3A and B:
FLAG, C,D: GFP. Note that identical data were obtained if the tags
were reversed, that is, the kinase-dead PIPkin Ic93 was FLAG tagged,
and active PIPkin Ic93 or Ic90 were tagged with GFP (not shown).
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tants also controlled for possible non-speciﬁc misfolding arte-
facts [16]. When we investigated the localisation of one of these
(D316K), it showed a plasma membrane localisation identical
to the active PIPkin Ic90 enzyme (not shown). When we exam-
ined it by FRAP in HEK293 cells, the half-life of the kinase-
dead enzyme appeared to be diﬀerent from the active enzyme
(Table 1). However, the more rigorous analysis employed to
compute D, which takes into account the relative size of the
ROI versus the cell and other variables (see [17] for a full dis-
cussion of this issue) revealed no signiﬁcant diﬀerence (by T
test) between the two enzymes.
This suggests that whatever the contribution of PtdIns4P
binding may be to Type I PIPkin localisation [19,20], synthesis
of PtdIns(4,5)P2 by the Type Ic90 PIPkin does not seem to be
an important factor in its location in these experiments, or in
its interactions as revealed by FRAP.
3.6. Kinase-dead PIPkin Ic93
We also investigated the behaviour of the two diﬀerent ki-
nase-dead PIPkin Ic93 mutants that we used in Ref. [16] in
both COS and HEK293 cells. In both cell lines the location
of D316K and K138A was quite distinct from the active en-
zyme, appearing to be entirely cytosolic (exempliﬁed by the
D316K mutant, shown in Figs. 1F and 2D and H). Moreover,
when we investigated the mobility of PIPkin Ic93 D316K by
FRAP the mobile fraction was 92% (Table 1), with a computed
D of 3.54 lm2 s1 (Table 1). The only direct comparison we
can make for a cytosolic protein of similar size and dimensions
is with our own measurement of GFP-GAP1m when it is cyto-
solic, which had a diﬀusion coeﬃcient of 5.56 lm2 s1 [17], and
so within the limits of this technique we can suggest that the
kinase-dead PIPkin Ic93 is probably freely diﬀusable in the
cytosol.
Simplistically, the remarkable diﬀerence in localisation and
mobility between active and inactive PIPkin Ic93 has two
explanations: Either, (a) the localisation of PIPkin Ic93, to
whatever compartment it is in, depends on its ability to synthe-
sise PtdIns(4,5)P2; or, (b) the endogenous enzyme is truly cyto-
solic (here faithfully reﬂected by the kinase-dead construct),
and that transfection with an excess of active enzyme has in-
duced an artefactual change in the cells’ physiology, reﬂected
in a changed localisation of the enzyme.
To provide some further insight into this issue we co-trans-
fected live and dead PIPkin Ic constructs, and the images
(Fig. 3) show that this did not alter their subcellular localisa-
tion; that is, the kinase-dead PIPkin Ic93 remains cytosolic
even if co-expressed with active PIPkin Ic93 (Fig. 3C) or active
PIPkin Ic90 (Fig. 3D), and both of the active Type Ics, Ic93
and Ic90, are unaﬀected by the co-transfection with kinase-dead PIPkin Ic93 (Fig. 3A and B, respectively). Thus it seems
that it is the actual ability of the enzyme to synthesise
PtdIns(4,5)P2 that dictates its localisation, and not a general
increase in PtdIns(4,5)P2 in the relevant compartment.
There is an interesting parallel here with the observations of
Ling et al. [10,11], who showed a diﬀerence in localisation be-
tween active and inactive PIPkin Ic90s, speciﬁcally in their
localisation to focal adhesions in spreading cells. They sug-
gested that this is probably caused by the lesser degree to
which the kinase-dead enzyme is tyrosine phosphorylated,
which in turn dictates a decreased association with talin
[11,12]. It may be that PIPkin Ic93 also requires phosphoryla-
tion to localise it, and that it needs to be active for this to oc-
cur. But if that is so, then for both PIPkin Ic93 and for PIPkin
Ic90 [10,11], exactly why the enzyme’s ability to synthesise
PtdIns(4,5)P2 should alter its eﬃcacy as a substrate for a pro-
tein kinase, is a question to which there is no clear answer at
present.
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PIPkin Ic constructs catalytically dead target their ATP and
Mg2+ binding site [16], and should not aﬀect their interaction
with PtdIns4P. So, the diﬀerence between localisations of the
kinase-dead PIPkin Ic93 versus the kinase-dead PIPkin Ic90
(Table 1) provides extra evidence that there is more to the plas-
ma membrane localisation of PIPkin Ic90 than binding of
PtdIns4P. It implies that there must be protein–protein inter-
actions involved, interactions that are presumably prevented
by the extra 26 amino acids in PIPkin Ic93 [16]. This again
emphasises the uniqueness of PIPkin Ic93 amongst the Type
I PIPkin family. In conclusion, our data not only highlight
the potential complexities of the regulation of the synthesis
of diﬀerent pools of PtdIns(4,5)P2, but more generally illus-
trate the way in which alternative splicing can generate physi-
ological diversity.Acknowledgements: We thank Dave Brough for many helpful discus-
sions, and one of the reviewers of the manuscript for useful sugges-
tions. M.-L.G. is supported by a Project Grant from the Wellcome
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